Dexcom (DXCM)

R&D to Revenue

11.69%

Quarterly · Period ending:

DXCM logo

DXCM R&D to Revenue

Latest reported11.69%
DXCM Quarterly R&D/Revenue (0.00% → 11.69%)
High-resolution chart · PNG

DXCM r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom R&D to Revenue — Quarterly
Period endingR&D to Revenue
11.6937%
12.1906%
11.7656%
13.0241%
12.8079%
14.0154%
12.5281%
13.619%
13.5418%
15.3637%
13.1561%
13.4769%
13.6922%
16.0486%
14.2664%
14.3321%
17.4806%
21.6126%
33.9301%
19.8093%
21.6938%
21.6634%
20.9527%
17.5085%
17.6848%
18.0449%
17.0268%
16.8307%
20.5113%
21.0339%
81.4497%
18.7852%
19.4639%
24.295%
22.0362%
23.4561%
26.5533%
33.8018%
25.5257%
29.5424%
26.4385%
27.7108%
21.789%
61.597%
26.1803%
27.1978%
25.6228%
26.8116%
25.1701%
30.7856%
24.3714%
27.5058%
31.0056%
31.4189%
26.1679%
45.8313%
44.7676%
48.3454%
41.1757%
45.0915%
32.759%
44.2218%
44.1417%
52.8206%
46.0292%
49.649%
39.8434%
48.1609%
51.1776%
60.8404%
112.2269%
282.1875%
242.0283%
260.0967%
287.7618%
299.9183%
466.7439%
398.7154%
470.6921%
551.0163%
1,119.1119%
37,185.0085%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.